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Intravascular optical coherence tomography (OCT) is a useful tool for the detection
of a thin layer of neointimal hyperplasia (NIH) and malapposition with high-
resolution (≥ 10 µm).1-5 ST-elevation myocardial infarction (STEMI) is associated
with a higher risk of stent thrombosis and malapposition may be a surrogate
marker.6-8 Currently, available drug eluting stents (DES) have different properties of
stent expansion and apposition. However, the data are lacking in initial findings
Original Article DOI 10.3349/ymj.2010.51.3.332pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 51(3): 332-338, 2010
The Initial Extent of Malapposition in ST-Elevation
Myocardial Infarction Treated with Drug-Eluting Stent:
The Usefulness of Optical Coherence Tomography
Ung Kim,1 Jung-Sun Kim,2 Jin-Sun Kim,2 Jung-Myung Lee,2 Jung-Woo Son,2 Jaedeok Kim,2
Young-Guk Ko,2 Donghoon Choi,2 and Yangsoo Jang2
1Division of Cardiology, Inje University College of Medicine, Pusan Paik Hospital, Busan;
2Division of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea.
Purpose: The aim of this study is to identify the extent of initial malapposition
using optical coherence tomography (OCT) in ST-elevation myocardial infarctions
(STEMI) treated with different types of drug-eluting stents (DES). Materials and
Methods: Twenty four STEMI patients that underwent primary percutaneous
coronary intervention (PCI) were enrolled. The OCT and intravascular ultrasound
(IVUS) were performed within 72 hours after the primary PCI. Distances between
the endo-luminal surface of the strut reflection and the vessel wall and the extent of
malapposition were measured and analyzed. Results: Sirolimus-eluting stents
(SES), paclitaxel-eluting stents (PES) and zotarolimus-eluting stents (ZES) were
deployed in 7 patients (29%), 7 patients (29%) and 10 patients (42%). In total,
4951 struts in 620 mm single-stent segments were analyzed (1463 struts in SES,
1522 in PES, and 1966 in ZES). In strut analysis by OCT, the incidence of
malapposition was 17 % (860/4951) and in stent analysis by IVUS, malapposition
rate was 21% (5/24). The malapposition rate of strut level using OCT in 5 patients
who had malapposition in IVUS was significantly higher than the 19 of those who
had not (32 ± 5% vs. 12 ± 6%, p = 0.001). In addition, the frequency of malap-
position was also significantly different (28% in SES, 11% in PES, 10% in ZES, p
= 0.001). The use of SES was an independent predictor of malapposed struts.
Conclusion: The incidence of malapposition using OCT was quite prevalent in
STEMI after primary PCI with DES implantation and SES has especially higher
rates of malapposition compared to other DESs.
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INTRODUCTION
such as malapposition using OCT in STEMI treated with
DES. The aim of this study is to identify the extent of initial
malapposition using OCT in STEMI treated with DES and
to compare the results between different stent types.
Study population and protocol
Twenty four patients (20 males, 83%) who were diagnosed
with STEMI and underwent primary percutaneous coro-
nary intervention (PCI) were enrolled from Aug. 2007 to
Mar. 2008 in the Cardiovascular Hospital of Yonsei Uni-
versity Medical Center. The study protocols were approved
by the institutional ethics committee of Yonsei University
College of Medicine, and written consent was obtained from
all patients before the procedure. Emergency coronary
angiography and primary PCI were performed by the
femoral approach according to standard techniques in each
of the patients. Using a guiding catheter for magnification
and calibration, quantitative coronary angiography was
performed immediately after the procedure. OCT was per-
formed in infarct-related arteries treated with DES at the
second stage within 72 hours of the primary PCI. STEMI
was defined as continuous chest pain lasting > 30 min, with
arrival at our hospital within 12 hours from the onset of the
symptom, with ST-segment elevation ≥ 0.1 mV in two or
more contiguous leads on 12-lead electrocardiogram and
elevation of serum cardiac enzymes such as troponin and/or
creatine kinase-MB (CK-MB). The luminal diameter
proximal to the culprit lesion was required to be between
2.5 mm and 4.0 mm due to the maximal diameter of the
currently available occlusion balloon. Exclusion criteria
were poor left ventricular function (< 30% of ejection
fraction), hemodynamic instability, significant left main
coronary artery disease, renal insufficiency with baseline
serum creatinine > 1.5 mg/dL, a single remaining vessel,
highly tortuous vessels, and ostial or very proximal lesions
(< 15 mm from ostium).
Adjunctive medication
All patients received an intravenous bolus injection of 5,000
U of heparin. In primary PCI in STEMI, 200 mg of aspirin
was given before the procedure and 600 mg of clopidogrel
was given during the surgery. After the PCI, both drugs
were continuously administered for at least 12 months. The
use of glycoprotein IIb/IIIa inhibitors was left to the discre-
tion of the operator.
Intravascular ultrasound examination
An intravascular ultrasound (IVUS) was performed during
primary PCI if needed. However, it was done concurrently
with OCT within 72 hours and the data was analyzed.
IVUS assessment was performed using a commercially
available IVUS system (Boston Scientific/Scimed, Natick,
MA, USA) with automatic motorized 0.5 mm/s pullback.
All IVUS procedures were performed after intracoronary
administration of nitroglycerin 200 µg. Studies were record-
ed on a compact disk for offline analysis using Index (Echo-
plaque 2; INDEC System, Inc., Mountain View, CA, USA).
Proximal reference cross-sectional area (CSA, mm2) and
distal reference CSA (mm2) were measured at the most
visually normal area (largest lumen with the least plaque
burden) within 10 mm of the proximal or distal ends of the
lesion. Malapposition was defined as the separation of at
least 1 stent strut from the intimal surface of the arterial
wall that was not overlapping a side branch and had evi-
dence of blood flow (speckling) behind the strut.9
OCT examination
The OCT system used in this study consisted of a computer,
a monitor display, an interface unit (Model M2 Cardiology
Imaging System, LightLab Imaging, Inc., Westford, MA,
USA), and a 0.014-inch wire-type imaging catheter (Image-
Wire, LightLab Imaging, Inc., Westford, MA, USA). A
motorized pull-back system at 1.0 mm/s was used, and OCT
images were acquired at 15 frames/s. The axial resolution
capacity of this system was 15 µm. All patients were given
5,000 IU of heparin intravenously before their respective
procedures. A 6Fr or 7Fr guiding catheter was introduced
into the coronary artery by a femoral approach, and nitrogly-
cerin (200 µg) was administered through the guiding
catheter. To remove the blood from the field of view and
allow for clear images, an occlusion balloon catheter (Helios,
Avantec Vascular Corp., Sunnyvale, CA, USA) and flush-
ing with warm lac was used in an over-the-wire type method
with the flush lumen and the lumen for crossing the imag-
ing catheter. There were two metal markers at the tip and
at the center of the occlusion balloon. The occlusion catheter
was positioned proximal to the stent and the image catheter
was positioned distal to the stent. During image acquisition,
the occlusion balloon was inflated at 0.4 to 0.6 atm and
Ringer lactate was infused at 0.5 to 1.0 mL/s. The image
wire was pulled from distal to proximal, and continuous
images were stored digitally for subsequent analysis.
OCT analysis
Cross-sectional OCT images were analyzed at 1-mm inter-
vals (every 15 frames). Stent struts appeared as highly
reflective surfaces that cast shadows on the vessel wall
behind. The distances between the endo-luminal surface of
the strut reflection and the vessel wall were measured by
prolonging and joining the contours of the wall on either
side of the strut shadow with a measurement line as perpen-
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MATERIALS AND METHODS
dicular as possible to the strut and vessel wall (Fig. 1).
When the strut was not fully attached to the vessel wall by
visual estimation, the position of the stent strut to the vessel
wall was measured by magnifying the individual stent strut
to maximize accuracy. Malapposed stent struts were defin-
ed as struts with detachment from the vessel wall ≥ 160 µm
for sirolimus-eluting stents (SES; Cypher select, Cordis,
J&J, East Bridgewater, NJ, USA), ≥ 130 µm for paclitaxel-
eluting stents (PES; Taxus Liberte, Boston Scientific,
Natick, MA, USA), and ≥ 110 µm for zotaroliums-eluting
stents (ZES; Endeavor, Medtronic, Minneapolis, MN,
USA).10 Stent overlapping segments and bifurcation lesions
with major side branches were excluded from this analysis.
Inter-observer and intra-observer variabilities in measured
distances were assessed by the evaluation of 20 random
cross-sectional images by two independent readers and by
the same reader at two separate time points, respectively.
The variations between measurements were calculated
using the linear mixed model (one-way mixed and two-
way mixed models).
Statistical analysis
Results are expressed as a mean ± SD or number (%).
Comparisons of categorical variables were made using the
Chi-square test and the student’s t-test while one way
ANOVA were used to compare continuous variables. The
intra-observer and inter-observer agreements (reproduci-
bility) were assessed by determining the mean ± SD of
differences between observations and between observers,
respectively. If the distributions were skewed, a non-para-
metric test was used. Because the observation of struts in
the same stent is not independent of each other and the
hierarchical nature of the data, mixed effect multiple logis-
tic regression with malapposition as the outcome variable
was applied to address random and fixed effects at the strut,
lesion and patient levels. At the lesion level, stent type (SES
versus non-SES), stent diameter, stent length, reference
vessel diameter, minimal luminal diameter and maximum
inflation pressure were considered. At the patient level, age,
sex and diabetes mellitus were considered.11 All analyses
were performed using the Statistical Analysis System
software (SAS 9.1.3., SAS Institute, Cary, NC, USA; and
R 2.8.1., R Foundation, Vienna, Austria) and p < 0.05 was
considered statistically significant.
Baseline characteristics and angiographic findings
Baseline characteristics of patients are presented in Table 1.
The patients’ mean age was 59 ± 10 years and they were
predominantly male. Seventy percent of patients (16, 66%)
had multi-vessel disease, with culprit lesions predomina-
tely in the left descending artery (14, 58%). SES was
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RESULTS
Fig. 1. Measurements of strut apposition. The distances between the endo-luminal surface of the strut reflection and the vessel wall were measured. (A and B) shows
OCT image of SES and strut measurements and represents malapposition. (C and D) shows OCT image of PES and strut measurement shows normal stent apposition.
(E and F) represents OCT image of ZES and its measurement shows normal stent apposition. Definition of malapposition: ≥ 160 µm for SES, ≥ 130 µm for PES, ≥ 110 µm
for ZES.7 OCT, optical coherence tomography; SES, sirolimus-eluting stent; PES, paclitaxel-eluting stent; ZES, zotarolimus-eluting stent.
A C E
B D F
implanted in 7 patients (29%), PES in 7 patients (29%),
and ZES in 10 patients (42%). Angiographic results are
shown in Table 2. A pre-stenting balloon was applied in all
patients. High pressures (15.0 ± 2.0 atm) were applied in
all implanted stents but it was not statistically significant
(Table 3). The quantitative angiographic analysis in each
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Table 1. Baseline Characteristics of Patients
Patients n = 24 (%)
Age (yrs) 59 ± 10
Male 20 (83)
Diabetes mellitus 8 (33)
Hypertension 15 (63)
Current smoker 11 (46)
Hyperlipidemia 15 (63)
Low density lipoprotein (mg/dL) 122 ± 29
Previous History
Stroke 1 (4)
Myocardial infarction 1 (4)
Intervention or CABG 0
Ejection fraction (%) 49 ± 9
Peak creatine kinase-MB (mg/dL) 224 ± 189
CABG, coronary artery bypass graft.
Values are presented as means ± SD or percentages.
Table 2. Angiographic Results of Patients
Patient n = 24 (%)
Pre TIMI 0 11 (46)
Lesion length, mm 25 ± 6
Types of lesion
A 2 (8)
B1 9 (38)
B2 8 (33)
C 5 (21)
Diseased vessel, n (%)
1 vessel 8 (34)
2 vessel 14 (58)
3 vessel 2 (8)
Culprit lesion, n (%)
RCA 7 (29)
LAD 14 (58)
LCX 3 (13)
Drug eluting stent, n (%)
Sirolimus eluting stent 7 (29)
Paclitaxel eluting stent 7 (29)
Zotarolimus eluting stent 10 (42)
RCA, right coronary artery; LAD, left anterior descending artery; LCX, left 
circumflex artery.
Values are presented as mean ± SD or percentages.
Table 3. Procedural Results, Quantitative Coronary Angiographic Analysis and IVUS Measurements Among Stents
Total (n = 24) SES (n = 7) PES (n = 7) ZES (n = 10) p value
Pre-stenting ballooning (n, %) 24 (100%) 7 (100%) 7 (100%) 10 (100%) 1.00
Stent size (mm) 3.0 ± 0.2 2.9 ± 0.1 3.0 ± 0.2 3.1 ± 0.3 0.32
Stent length (mm) 25.8 ± 6.8 27.3 ± 5.3 28.0 ± 8.5 23.3 ± 6.1 0.31
Maximal pressure (atm) 15.3 ± 2.1 15.7 ± 2.4 14.8 ± 2.3 15.4 ± 1.9 0.76
Stent to artery ratio 1.10 ± 0.09 1.13 ± 0.09 1.05 ± 0.11 1.11 ± 0.08 0.31
Proximal reference diameter (mm) 3.0 ± 0.4 2.9 ± 0.2 3.0 ± 0.4 3.1 ± 0.4 0.57
Distal reference diameter (mm) 2.5 ± 0.4 2.3 ± 0.4 2.7 ± 0.4 2.5 ± 0.5 0.33
Pre-intervention
Minimal lumen diameter (mm) 0.4 ± 0.4 0.2 ± 0.3 0.3 ± 0.5 0.5 ± 0.4 0.31
Diameter stenosis (%) 85.6 ± 16.3 90.1 ± 16.1 88.9 ± 16.5 79.4 ± 15.8 0.30
Post-intervention
Minimal lumen diameter (mm) 2.8 ± 0.3 2.6 ± 0.1 2.9 ± 0.3 2.8 ± 0.3 0.17
Diameter stenosis (%) 6.6 ± 6.5 9.2 ± 4.9 3.6 ± 5.1 6.8 ± 8.1 0.30
Post-intervention IVUS parameters (mm2)
Proximal reference EEM CSA 15.3 ± 3.6 15.3 ± 4.0 15.3 ± 2.3 15.3 ± 4.4 0.99
Proximal reference lumen CSA 7.7 ± 2.1 6.9 ± 2.0 7.4 ± 1.8 8.6 ± 2.1 0.25
Lesion-segment EEM CSA 13.1 ± 3.3 12.1 ± 3.5 13.7 ± 3.6 13.4 ± 2.9 0.65
Lesion-segment lumen CSA 5.4 ± 1.4 4.4 ± 1.1 5.1 ± 0.8 6.5 ± 1.3 0.00
Distal reference EEM CSA 10.1 ± 3.1 9.2 ± 2.4 10.8 ± 3.3 10.2 ± 3.6 0.64
Distal reference lumen CSA 6.4 ± 1.7 6.4 ± 2.1 5.9 ± 0.6 6.8 ± 2.1 0.62
IVUS, intravascular ultrasound; SES, sirolimus-eluting stent; PES, paclitaxel-eluting stent; ZES, zotarolimus-eluting stent; EEM, external elastic membrane; CSA, 
cross sectional area.
Values are presented as means ± SD or percentages.
group is shown in Table 3.
IVUS measurements
Post-intervention IVUS measurements are represented in
Table 3. Among the groups, IVUS parameters were not
significantly different except for minimal stent CSA. The
initial rate of malapposition measured by IVUS was 21%,
and had a higher trend toward to SES. 
OCT measurements
The total number of measured struts was 4951, including
1463 (30%) in SES, 1522 (31%) in PES, and 1966 (39%)
in ZES. The average distances between the lumen and
stent were different, and the SES was significantly longer
than the other stents (188 ± 46 in SES, 144 ± 18 in PES,
127 ± 34 in ZES, p = 0.00) (Fig. 2). The numbers of malap-
position struts were 28% in SES, but only 11% in PES and
10% in ZES; the malapposition rates of SES were signi-
ficantly higher than those of the other two stents (Fig. 3).
The rate of malapposition of 5 patients who had malap-
position in IVUS showed 32% in strut level by OCT but,
12% in 19 patients who had not and this is statistically
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Table 4. Malapposition Rates in Optical Coherence Tomography (OCT) according to the Results of Intravascular 
Ultrasound (IVUS)
Parameters
Malapposition in IVUS No malapposition in IVUS
p value
(n = 5) (n = 19)
Total struts by OCT, n 233 ± 44 199 ± 77 0.36
Number of malapposition struts, n 73 ± 16 26 ± 16 0.00
Malapposition rate, % 32 ± 5 12 ± 6 0.00
OCT, optical coherence tomography; IVUS, intravascular ultrasonography.
Values are presented as means ± SD or percentages.
Table 5. Multivariate Predictors of Malapposed Struts 
Estimate 95% CI p value
Stent type
SES vs. PES 3.45 2.33 - 5.26 < 0.00
SES vs. ZES 3.12 2.08 - 4.54 < 0.00
Maximal balloon pressure 1.17 1.08 - 1.27 < 0.00
Stent size 0.28 0.09 - 0.85 0.02
Reference vessel diameter 1.83 1.05 - 3.20 0.03
ZES, zotarolimus-eluting stent; MLD, minimal luminal diameter; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent.
Independent predictors of malapposed strut was identified using mixed effect multivariate logistic analysis after controlling age, gender,
diabetes, stent type (SES versus non-SES), stent size, stent length, reference vessel diameter, minimal luminal diameter and maximum
inflation pressure.
Fig. 2. Average distances between lumen and stent. *Represents statistical
significance (p = 0.00). Definition of incomplete stent apposition: ≥ 160 µm for
SES, ≥ 130 µm for PES, ≥ 110 µm for ZES. SES, sirolimus-eluting stent; PES,
paclitaxel-eluting stent; ZES, zotarolimus-eluting stent.7 
Fig. 3. Comparison of malapposition strut numbers according to stent.
*Represents statistical significance (p = 0.00), �indicates non-significant results
(p = 0.81). Definition of malapposition: ≥ 160 µm for SES, ≥ 130 µm for PES, ≥ 110
µm for ZES.7 SES, sirolimus-eluting stent; PES, paclitaxel-eluting stent; ZES,
zotarolimus-eluting stent.
significant (32 ± 5% vs. 12 ± 6%, p = 0.00) (Table 4).
If we consider the definition of stent malapposition in
OCT as having malapposed struts over 10% in all struts,
the malapposition rate was 67% (16/24) or if over 5%, 83%
(20/24) or if any malapposition, 100% (24/24). Regarding
sensitivity of OCT as 100%, that of IVUS could be calcul-
ated as 33%.
The intra-observer correlation coefficient between varia-
bility of observer1 was 0.981 (95% CI: 0.975-0.985) using
the one-way mixed model, where patient effects are random.
The inter-observer correlation coefficient between the
variability of two observers using the two-way mixed mo-
del, where patient effects are random and observers effects
are fixed, were 0.982 (95% CI: 0.977-0.986) and  0.983
(95% CI: 0.978-0.987), respectively. Multivariate predic-
tors of malapposed stent struts on mixed effect logistic
regression analysis are shown in Table 5. The use of SES
was an independent predictor of malapposed struts toge-
ther with large reference vessel diameter, small stent size
and high maximal pressure. 
This may be the first report assessing initial malapposition
in STEMI patients undergoing primary PCI by OCT. The
major findings of this paper indicate that the considerable
rates of malapposition using OCT were detected during
primary PCI in STEMI patients treated with DES and total
malapposition rates were 17% but malapposition rates in
SES were significantly higher than those of other DESs
(28% in SES vs. 11% in PES vs. 10% in ZES, p = 0.00).
SES was also an independent predictor of a malapposed
strut after controlling the patients and lesion factors.
The frequency of initial stent malapposition by IVUS
was previously reported and the rates from the results had
such a wide range that one study showed the rates were as
low as 8.7% in SES and 2.4% in PES, but another studies
showed 16% in SES, 19% in SES and 12.6% in ZES.9,12,13
However, previous reports have a heterogeneous study
population from stable angina to acute myocardial infarc-
tion. We performed IVUS before OCT in all patients
performing primary PCI diagnosed as STEMI, therefore,
the initial rates of malapposition on IVUS seemed to be
relatively higher than those of the above mentioned report
(21% vs. 11 to 19%). Also these variable rates of malappo-
sition might be affected due to unique characteristics of
each stent like strut thickness. This malapposition rate on
IVUS was comparable with OCT findings although there
was somewhat different method of measurement (21% in
IVUS vs. 16% in OCT). But, IVUS cannot measure stent
struts more accurately than OCT, because the IVUS resolu-
tion to evaluate each strut of a stent compared to OCT is
limited. 
OCT can accurately measure the intima-media thickness
and identify fine abnormal structures such as detailed
components of coronary atherosclerotic plaques, hema-
toma, dissection, intra-stent tissue prolapse, stent fracture,
and stent malapposition.14-17 The present study implies
specific subsets of patients with STEMI after primary PCI
with OCT. Although SES is effective in preventing reste-
nosis, currently their safety has been questioned and many
defects such as stent fractures and malapposition have
been challenging. Therefore, initial malapposition might
be possible to be relate to late clinical outcomes of SES.
Although we do not know the clinical implication of initial
malapposition, it is certain that this finding is too signifi-
cant to pass over and could not exclude the association
with late clinical adverse events such as stent thrombosis
through the inhibition of healthy endothelial cell growth
and neointimal coverage of stent strut. Given that SES has
a relatively stronger and thicker stent strut body than other
stents, malapposition may occur more often; nevertheless,
high pressure is applied. This finding suggests that malap-
position might have a role to retard the neointimal growth
addition to the effects of the immunosuppressant drug and
polymer because SES have been know to reduced the
significantly neointima than other DESs. These concepts
were also evidenced by Tanigawa, et al.11 They showed
that despite angiographic optimization with high pressures
and adequately sized balloons, malapposed stent struts are
frequently found in implantation of Cypher Select stents
which have a thicker stent strut and closed cell design.
Therefore, the present study suggests that a close clinical
follow-up and strict dual anti-platelet therapy may be
necessary to prevent the cardiac events after DES implan-
tation in STEMI because vulnerability could remain even
in successful treatment with DES. 
One limitations of this study is that only the initial period
after the stent was evaluated. Therefore, the follow-up
OCT and clinical finding are needed to investigate and
although this was not performed in the current study it is
now in progress. Another limitation is the number of pa-
tients, which was fairly small and there is the possibility of
selection bias, although the measured strut number was
quite large. However, we believe that this study is valuable
because it is the first report about the initial extent of
malapposition of DES using OCT during primary PCI.
Another limitation is that this malapposition observed within
72 hours after stenting may be associated with procedural
issues. However, we performed a primary PCI by one fully
experienced operator and the procedures including balloon-
ing or high pressure before and after stenting were also
standardized in all patients to reduce errors.
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DISCUSSION
In conclusion, considerable rates of malapposition were
detected in STEMI after primary PCI with DES implan-
tation and OCT can be a useful tool for finding an initial
malapposition.
Furthermore, follow-up clinical, angiographic, and OCT
findings of stent malapposition are needed to evaluate the
clinical implications and fate of initial stent malapposition
in STEMI after primary PCI. 
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